Wednesday, August 6, 2025

Ventripoint Diagnostics To Collaborate With GE Healthcare

Ventripoint Diagnostics (TSXV: VPT) this morning announced a major arrangement. The company has officially entered into a collaboration with that of GE Healthcare, a subsidiary of General Electric (NYSE: GE).

The collaboration will see Ventripoint included within GE’s Edison Developer Program as an innovator. The program is designed to help healthcare providers gain access to market-ready applications, with the program also expected to bring more functionality to the firms cardiac ultrasounds devices..

The arrangement will effectively see the installed base be enhanced for Ventripoint, while also driving commercial growth worldwide via access to GE’s global sales channels. These sales channels under the collaboration will also have the potential to see VPT’s advanced 3D image analysis tools used for studies.

“We are delighted to partner with GE Healthcare to work towards bringing our cardiac analysis tools to their existing customer base of cardiologists,”

Dr. George Adams, Executive-Chairman of Ventripoint

Ventripoint Diagnostics last traded at $0.64 on the TSX Venture.


FULL DISCLOSURE: Ventripoint Diagnostics is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Ventripoint Diagnostics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Ventripoint Looks To Raise $5.0 Million Via Bought Deal

Ventripoint Diagnostics (TSXV: VPT) this evening was halted for trading, ahead of announcing that the...

Tuesday, September 28, 2021, 07:33:00 AM

Citron Calls Markolpolos GE Short Report Reckless, Dishonest, and Secretive

This afternoon, Andrew Left’s outfit Citron Research took on Harry Markolpolos’ GE Short report issued...

Friday, August 16, 2019, 01:38:04 PM

Ventripoint Files For Provisional Patent On Heart Motion Tracking Tech

Ventripoint Diagnostics (TSXV: VPT) is evidently looking to grow its portfolio of intellectual property. The...

Monday, April 19, 2021, 09:44:24 AM

Ventripoint Joint Venture Begins Device Certification For Use In Covid Patients In China

Ventripoint Diagnostics (TSXV: VPT) is progressing with its joint venture partner in China. This morning...

Tuesday, March 16, 2021, 09:29:18 AM

Ventripoint Installs Whole Heart Analysis System At Toronto General Hospital

Ventripoint Diagnostics (TSXV: VPT) has seen its technology installed at the largest cardiac centre in...

Thursday, November 5, 2020, 10:47:10 AM